MAPK3 and neoplasm: The downstream signaling pathway involves mitogen-activated protein kinase (MAPK, ERK1/2) or phosphatidylinositol 3-kinase (PI3K), and can result in the stimulation of angiogenesis and of tumor cell growth (15–18).